Genetic Modifiers of Long‐Term Survival in Sickle Cell Anemia

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Modifiers of Long‐Term Survival in Sickle Cell Anemia Received: 10 July 2020 Revised: 30 July 2020 Accepted: 31 July 2020 Published online: 10 August 2020 DOI: 10.1002/ctm2.152 RESEARCH ARTICLE Genetic modifiers of long-term survival in sickle cell anemia Ambroise Wonkam1,2 Emile R. Chimusa1,2 Khuthala Mnika1 Gift Dineo Pule1 Valentina Josiane Ngo Bitoungui1 Nicola Mulder3 Daniel Shriner4 Charles N. Rotimi4 Adebowale Adeyemo4 1 Division of Human Genetics, Institute of Infectious Disease and Molecular Abstract Medicine (IDM), Faculty of Health Background: Sickle cell anemia (SCA) is a clinically heterogeneous, monogenic Sciences, University of Cape Town, Cape disorder. Medical care has less-than-optimal impact on clinical outcomes in SCA Town, South Africa 2 Institute of Infectious Disease and in Africa due to several factors, including patient accessibility, poor access to Molecular Medicine (IDM), Faculty of resources, and non-availability of specific effective interventions for SCA. Health SciencesUniversity of Cape Town, Methods: Against this background, we investigated 192 African participants Cape Town, South Africa who underwent whole exome sequencing. Participants included 105 SCA 3 Computational Biology Division, Department of Integrative Biomedical patients spanning variable clinical expression: a “long survivor” group (age over Sciences, Institute for Infectious Disease 40 years), a “stroke” group (at least one episode of overt stroke), and a “random” and Molecular Medicine, University of group (patients younger than 40 years without overt cerebrovascular disease). Cape Town, Cape Town, South Africa 4 Center for Research on Genomics and Fifty-eight ethnically matched homozygous hemoglobin A controls were also Global Health, National Human Genome studied. Findings were validated in an independently recruited sample of 29 SCA Research InstituteNational Institutes of patients. Statistical significance of the mutational burden of deleterious and loss- Health, Bethesda, Maryland, USA of-function variants per gene against a null model was estimated for each group, Correspondence and gene-set association tests were conducted to test differences between groups. Ambroise Wonkam, MD, PhD, Divi- Results: In the “long survivor” group, deleterious/loss-of-function variants were sion of Human Genetics, Department of Medicine, Institute of Infectious Disease enriched in genes including CLCN6 (a voltage-dependent chloride channel for and Molecular Medicine, Faculty of Health which rare deleterious variants have been associated with lower blood pres- Sciences, University of Cape Town, Anzio sure) and OGHDL (important in arginine metabolism, which is a therapeutic Road, Observatory, 7925, Cape Town, South Africa. target in SCA). In the “stroke” group, significant genes implicated were asso- Email: [email protected] ciated with increased activity of the blood coagulation cascade and increased Funding information complement activation, for example, SERPINC1, which encodes antithrombin. NIH Clinical Center, Grant/Award Num- Oxidative stress and glutamate biosynthesis pathways were enriched in “long ber: U24-HL-135600; National Human survivors” group. Published transcriptomic evidence provides functional support Genome Research Institute, Grant/Award Number: 1U01HG007459-01; National for the role of the identified pathways. Institutes of Health, Grant/Award Num- Conclusions: This study provides new gene sets that contribute to variability in ber: 1ZIAHG200362 clinical expression of SCA. Identified genes and pathways suggest new avenues for other interventions. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. © 2020 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics Clin. Transl. Med. 2020;10:e152. wileyonlinelibrary.com/journal/ctm2 1of15 https://doi.org/10.1002/ctm2.152 2of15 WONKAM et al. KEYWORDS Africa, genetic modifiers, sickle cell disease, whole exome sequencing 1 INTRODUCTION lized a whole exome sequence (WES)-based approach to explore the specific hypothesis that rare gene-associated Sickle cell disease (SCD) is a group of blood disorders and function-altering variants with potentially high pen- caused by mutations in HBB that promote polymerization etrance are associated with SCA clinical sub-phenotypes,11 of hemoglobin and sickling of erythrocytes. The most com- and could lead to the identification of modifiable patho- mon and most clinically severe form of SCD is sickle cell physiological pathways. We studied two distinct clinical anemia (SCA [MIM: 603903]) and is caused by homozy- SCA groups, a “long survivor” group and a “stroke” group, gosity of the sickle mutation HbS. While the estimated age which we contrasted with a “random” group to infer criti- of the sickle mutation is ∼7300 years,1 the mutation has cal genes and pathways. We also contrasted the “long sur- persisted in appreciable frequencies because of the protec- vivor” and “stroke” groups as extreme phenotypes that are tion that heterozygotes have against malaria. An estimated likely to come from the relatively benign versus the most 305 800 babies are born each year with SCD worldwide, severe (respectively) ends of the phenotypic spectrum of with nearly 75% of the births occurring in sub-Saharan SCA. Africa (SSA).2 Despite this high incidence, most SSA coun- tries lack effective public health programs focused on SCD.3 2 MATERIALS AND METHODS Clinical expression of SCD often shows considerable variation in features such as the severity of anemia, the fre- 2.1 Ethics statement quency of painful vaso-occlusive crises, stroke, and mor- tality. Both genetic and non-genetic factors are known The study was performed in accordance with the guide- to influence the severity of SCD. For example, high fetal lines of the Helsinki Declaration. Ethical approval was hemoglobin (HbF) levels have long been known to be asso- given by the National Ethical Committee Ministry of Pub- ciated with less severity4; HbF levels are under genetic lic Health, Republic of Cameroon (No 033/CNE/DNM/07); control and are amenable to therapeutic manipulation.5 and the University of Cape Town, Faculty of Health Sci- Similarly, co-inheritance of α-thalassemia is protective ences Human Research Ethics Committee (HREC RE: against some SCD-related complications, such as hemol- 132/2010). ysis, stroke, and kidney disease.6,7 Availability of appro- priate comprehensive medical care for SCD that combines newborn screening, penicillin prophylaxis, screening for 2.2 Patients and methods stroke risk, transfusion program, and the use of hydrox- yurea, in high income countries, usually mitigates mor- Recruitment for the discovery group was conducted in bidity and facilitates longer survival of SCD patients.8 This Cameroon at the Yaoundé Central Hospital and Laquin- is, however, not the case in most of SSA, due to the com- tinie Hospital in Douala, as previously described.12 Socio- bined effect of inappropriate care and often severe clin- demographic and clinical data including blood counts and ical complications,7,9 compounded by other factors such hemoglobin (Hb) electrophoresis were obtained on enrol- as malaria, malnutrition, infectious diseases of childhood, ment. The present study was restricted to SCA (ie, HbSS), and poverty. Thus, up to 90% of infants with SCD in SSA the most prevalent and severe form of SCD. This study are believed to die needlessly by 5 years of age.10 design decision was taken to remove the potential con- Different HBB (MIM: 141900) haplotypes (Cameroon, founding effect of beta-thalassemia and hemoglobin C, Central African Republic, Benin, Senegal, and Ara- both of which are associated with milder forms of SCD. bian/Indian) have also been associated with variable clini- The discovery sample of patients included three groups. cal expression of SCD.2 However, a recent study of sickle (a) A “long survivor group” comprised SCA patients aged HBB haplotypes based on sequence data rather than over 40 years; this cut-off was based on a life expectancy of restriction site data led to a reclassification of the classical 43 years for SCA in the Cooperative Study.4 (b) A “stroke” haplotypes and found sub-structuring of haplotypes that group comprised SCA patients with at least one clini- may have confounded previous associations of the hap- cal episode of overt stroke, a devastating complication of lotypes with clinical severity.1 To search the genome for SCA that is considered to be a proxy of severity4 and is protein coding genes that affect disease severity, we uti- influenced by genetic modifiers.13 (c) A “random group” WONKAM et al. 3of15 comprised patients younger than 40 years with no independent subjects’ group, we filtered each resulting known cerebrovascular disease and randomly selected VCF file using the GATK tool Variant Filtration.16 Variant from among clinically stable patients. No patient was on filtering procedures and quality control assessment are as hydroxyurea, at the time of recruitment. Fifty-eight ethni- described in the Supporting Information Methods. Final cally matched homozygous HbAA controls were randomly call-sets were produced from VariantMetaCaller.17 We selected from apparently healthy blood donors recruited in used ANNOVAR to perform gene-based annotation (Sup- Yaoundé.14 The replication cohort consisted of adult SCA porting Information Methods) on
Recommended publications
  • Snps Related to Vitamin D and Breast Cancer Risk
    Huss et al. Breast Cancer Research (2018) 20:1 DOI 10.1186/s13058-017-0925-3 RESEARCHARTICLE Open Access SNPs related to vitamin D and breast cancer risk: a case-control study Linnea Huss1* , Salma Tunå Butt1, Peter Almgren 2, Signe Borgquist3,4, Jasmine Brandt1, Asta Försti5,6, Olle Melander2 and Jonas Manjer1 Abstract Background: It has been suggested that vitamin D might protect from breast cancer, although studies on levels of vitamin D in association with breast cancer have been inconsistent. Genome-wide association studies (GWASs) have identified several single-nucleotide polymorphisms (SNPs) to be associated with vitamin D. The aim of this study was to investigate such vitamin D-SNP associations in relation to subsequent breast cancer risk. A first step included verification of these SNPs as determinants of vitamin D levels. Methods: The Malmö Diet and Cancer Study included 17,035 women in a prospective cohort. Genotyping was performed and was successful in 4058 nonrelated women from this cohort in which 865 were diagnosed with breast cancer. Levels of vitamin D (25-hydroxyvitamin D) were available for 700 of the breast cancer cases and 643 of unaffected control subjects. SNPs previously associated with vitamin D in GWASs were identified. Logistic regression analyses yielding ORs with 95% CIs were performed to investigate selected SNPs in relation to low levels of vitamin D (below median) as well as to the risk of breast cancer. Results: The majority of SNPs previously associated with levels of vitamin D showed a statistically significant association with circulating vitamin D levels. Heterozygotes of one SNP (rs12239582) were found to have a statistically significant association with a low risk of breast cancer (OR 0.82, 95% CI 0.68–0.99), and minor homozygotes of the same SNP were found to have a tendency towards a low risk of being in the group with low vitamin D levels (OR 0.72, 95% CI 0.52–1.00).
    [Show full text]
  • Nicotinamide Riboside Kinases Display Redundancy in Mediating Nicotinamide Mononucleotide and Nicotinamide Riboside Metabolism in Skeletal Muscle Cells
    Original Article Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells Rachel S. Fletcher 1,2, Joanna Ratajczak 3,4, Craig L. Doig 1,2, Lucy A. Oakey 2, Rebecca Callingham 5, Gabriella Da Silva Xavier 5, Antje Garten 1,6, Yasir S. Elhassan 1,2, Philip Redpath 7, Marie E. Migaud 7, Andrew Philp 8, Charles Brenner 9, Carles Canto 3,4, Gareth G. Lavery 1,2,* ABSTRACT þ Objective: Augmenting nicotinamide adenine dinucleotide (NAD ) availability may protect skeletal muscle from age-related metabolic decline. þ Dietary supplementation of NAD precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) appear efficacious in elevating þ þ muscle NAD . Here we sought to identify the pathways skeletal muscle cells utilize to synthesize NAD from NMN and NR and provide insight into mechanisms of muscle metabolic homeostasis. þ Methods: We exploited expression profiling of muscle NAD biosynthetic pathways, single and double nicotinamide riboside kinase 1/2 (NRK1/ þ 2) loss-of-function mice, and pharmacological inhibition of muscle NAD recycling to evaluate NMN and NR utilization. Results: Skeletal muscle cells primarily rely on nicotinamide phosphoribosyltransferase (NAMPT), NRK1, and NRK2 for salvage biosynthesis of þ þ NAD . NAMPT inhibition depletes muscle NAD availability and can be rescued by NR and NMN as the preferred precursors for elevating muscle þ cell NAD in a pathway that depends on NRK1 and NRK2. Nrk2 knockout mice develop normally and show subtle alterations to their NADþ metabolome and expression of related genes. NRK1, NRK2, and double KO myotubes revealed redundancy in the NRK dependent þ metabolism of NR to NAD .
    [Show full text]
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation
    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
    [Show full text]
  • Open Data for Differential Network Analysis in Glioma
    International Journal of Molecular Sciences Article Open Data for Differential Network Analysis in Glioma , Claire Jean-Quartier * y , Fleur Jeanquartier y and Andreas Holzinger Holzinger Group HCI-KDD, Institute for Medical Informatics, Statistics and Documentation, Medical University Graz, Auenbruggerplatz 2/V, 8036 Graz, Austria; [email protected] (F.J.); [email protected] (A.H.) * Correspondence: [email protected] These authors contributed equally to this work. y Received: 27 October 2019; Accepted: 3 January 2020; Published: 15 January 2020 Abstract: The complexity of cancer diseases demands bioinformatic techniques and translational research based on big data and personalized medicine. Open data enables researchers to accelerate cancer studies, save resources and foster collaboration. Several tools and programming approaches are available for analyzing data, including annotation, clustering, comparison and extrapolation, merging, enrichment, functional association and statistics. We exploit openly available data via cancer gene expression analysis, we apply refinement as well as enrichment analysis via gene ontology and conclude with graph-based visualization of involved protein interaction networks as a basis for signaling. The different databases allowed for the construction of huge networks or specified ones consisting of high-confidence interactions only. Several genes associated to glioma were isolated via a network analysis from top hub nodes as well as from an outlier analysis. The latter approach highlights a mitogen-activated protein kinase next to a member of histondeacetylases and a protein phosphatase as genes uncommonly associated with glioma. Cluster analysis from top hub nodes lists several identified glioma-associated gene products to function within protein complexes, including epidermal growth factors as well as cell cycle proteins or RAS proto-oncogenes.
    [Show full text]
  • Metabolic Tracing of NAD Precursors Using Strategically Labelled Isotopes of NMN
    A thesis submitted in fulfilment of the requirements for the degree of Doctor of Philosophy Metabolic tracing of NAD+ precursors using strategically labelled isotopes of NMN by Lynn-Jee Kim Supervisors Dr. Lindsay E. Wu (Primary) Prof. David A. Sinclair (Joint-Primary) Dr. Lake-Ee Quek (Co-supervisor) School of Medical Sciences Faculty of Medicine Thesis/Dissertation Sheet Surname/Family Name: Kim Given Name/s: Lynn-Jee Abbreviation for degree as give in PhD the University calendar: Faculty: Faculty of Medicine School: School of Medical Sciences + Thesis Title: Metabolic tracing of NAD precursors using strategically labelled isotopes of NMN Abstract 350 words maximum: (PLEASE TYPE) Nicotinamide adenine dinucleotide (NAD+) is an important cofactor and substrate for hundreds of cellular processes involved in redox homeostasis, DNA damage repair and the stress response. NAD+ declines with biological ageing and in age-related diseases such as diabetes and strategies to restore intracellular NAD+ levels are emerging as a promising strategy to protect against metabolic dysfunction, treat age-related conditions and promote healthspan and longevity. One of the most effective ways to increase NAD+ is through pharmacological supplementation with NAD+ precursors such as nicotinamide mononucleotide (NMN) which can be orally delivered. Long term administration of NMN in mice mitigates age-related physiological decline and alleviates the pathophysiologies associated with a high fat diet- and age-induced diabetes. Despite such efforts, there are certain aspects of NMN metabolism that are poorly understood. In this thesis, the mechanisms involved in the utilisation and transport of orally administered NMN were investigated using strategically labelled isotopes of NMN and mass spectrometry.
    [Show full text]
  • Polymorphisms in GC and NADSYN1 Genes Are Associated with Vitamin
    Foucan et al. BMC Endocrine Disorders 2013, 13:36 http://www.biomedcentral.com/1472-6823/13/36 RESEARCH ARTICLE Open Access Polymorphisms in GC and NADSYN1 Genes are associated with vitamin D status and metabolic profile in Non-diabetic adults Lydia Foucan1,2,9*, Fritz-Line Vélayoudom-Céphise1,3, Laurent Larifla1, Christophe Armand1, Jacqueline Deloumeaux1, Cedric Fagour1, Jean Plumasseau4, Marie-Line Portlis5, Longjian Liu6, Fabrice Bonnet7 and Jacques Ducros8 Abstract Background: Our aim was to assess the associations between vitamin D (vitD) status, metabolic profile and polymorphisms in genes involved in the transport (Group-Component: GC) and the hydroxylation (NAD synthetase 1: NADSYN1) of 25 hydroxyvitamin D (25(OH)D) in non-diabetic individuals. Methods: We conducted a cross-sectional study with 323 individuals recruited from the Health Center of Guadeloupe, France. The rs2282679 T > G and rs2298849 T > C in GC and rs12785878 G > T in NADSYN1 were genotyped. Results: Mean age was 46(range 18–86) years. 57% of participants had vitD insufficiency, 8% had vitD deficiency, 61% were overweight and 58% had dyslipidemia. A higher frequency of overweight was noted in women carrying rs2298849T allele v CC carriers (71% v 50%; P = 0.035). The rs2282679G allele was associated with increased risks of vitD deficiency and vitD insufficiency (OR =3.53, P = 0.008, OR = 2.34, P = 0.02 respectively). The rs2298849 TT genotype was associated with vitD deficiency and overweight (OR =3.4, P = 0.004 and OR = 1.76, P = 0.04 respectively) and the rs12785878 GG genotype with vitD insufficiency and dyslipidemia (OR = 1.80, P = 0.01 and OR = 1.72, P = 0.03 respectively).
    [Show full text]
  • Prioritization of Variants for Investigation of Genotype-Directed Nutrition in Human Superpopulations
    International Journal of Molecular Sciences Article Prioritization of Variants for Investigation of Genotype-Directed Nutrition in Human Superpopulations 1, 1, 1 Pascal D. Nilsson y , Jacklyn M. Newsome y , Henry M. Santos and Martin R. Schiller 1,2,* 1 Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada Las Vegas, Las Vegas, NV 89154-4004, USA 2 Food Genes and Me LLC, 929 Via Doccia Court. Henderson, NV 89011, USA * Correspondence: [email protected] These authors contributed equally to this manuscript. y Received: 14 May 2019; Accepted: 16 July 2019; Published: 18 July 2019 Abstract: Dietary guidelines recommended by key health agencies are generally designed for a global population. However, ethnicity affects human disease and environment-gene interactions, including nutrient intake. Historically, isolated human populations with different genetic backgrounds have adapted to distinct environments with varying food sources. Ethnicity is relevant to the interaction of food intake with genes and disease susceptibility; yet major health agencies generally do not recommend food and nutrients codified by population genotypes and their frequencies. In this paper, we have consolidated published nutrigenetic variants and examine their frequencies in human superpopulations to prioritize these variants for future investigation of population-specific genotype-directed nutrition. The nutrients consumed by individuals interact with their genome and may alter disease risk. Herein, we searched the literature, designed a data model, and manually curated hundreds of papers. The resulting database houses 101 variants that reached significance (p < 0.05), from 35 population studies. Nutrigenetic variants associated with modified nutrient intake have the potential to reduce the risk of colorectal cancer, obesity, metabolic syndrome, type 2 diabetes, and several other diseases.
    [Show full text]
  • The Role of Natural Selection in Human Evolution – Insights from Latin America
    Genetics and Molecular Biology, 39, 3, 302-311 (2016) Copyright © 2016, Sociedade Brasileira de Genética. Printed in Brazil DOI: http://dx.doi.org/10.1590/1678-4685-GMB-2016-0020 Review Article The role of natural selection in human evolution – insights from Latin America Francisco M. Salzano1 1Departamento de Genética, Instituto de Biociências, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil. Abstract A brief introduction considering Darwin’s work, the evolutionary synthesis, and the scientific biological field around the 1970s and subsequently, with the molecular revolution, was followed by selected examples of recent investiga- tions dealing with the selection-drift controversy. The studies surveyed included the comparison between essential genes in humans and mice, selection in Africa and Europe, and the possible reasons why females in humans remain healthy and productive after menopause, in contrast with what happens in the great apes. At the end, selected exam- ples of investigations performed in Latin America, related to the action of selection for muscle performance, acetylation of xenobiotics, high altitude and tropical forest adaptations were considered. Despite dissenting views, the influence of positive selection in a considerable portion of the human genome cannot presently be dismissed. Keywords: natural selection, human evolution, population genetics, human adaptation, history of genetics. Received: February 10, 2016; Accepted: May 8, 2016. History deniably indicated that we had derived from
    [Show full text]
  • Vitamin D Status and Associated Genetic Polymorphisms in a Cohort of UK Children with Non- Alcoholic Fatty Liver Disease
    ORIGINALRESEARCH doi:10.1111/ijpo.12293 Vitamin D status and associated genetic polymorphisms in a cohort of UK children with non- alcoholic fatty liver disease P. S. Gibson1,3, A. Quaglia2, A. Dhawan3,H.Wu1, S. Lanham-New1, K. H. Hart1, RESEARCH E. Fitzpatrick3,† and J. B. Moore1,4,† 1Department of Nutritional Sciences, School of Summary Biosciences and Medicine, Faculty of Health and Background: Vitamin D deficiency has been associated with non-alcoholic fatty Medical Sciences, University of Surrey, Guildford, UK; 2Institute of Liver Studies, King’s College liver disease (NAFLD). However, the role of polymorphisms determining vitamin D ORIGINAL London School of Medicine at King’s College status remains unknown. Hospital, London, UK; 3Pediatric Liver, GI and Objectives: The objectives of this study were to determine in UK children with Nutrition Centre, King’s College London School of Medicine at King’s College Hospital, London, biopsy-proven NAFLD (i) their vitamin D status throughout a 12-month period and UK; 4School of Food Science and Nutrition, (ii) interactions between key vitamin D-related genetic variants (nicotinamide adenine University of Leeds, Leeds, UK dinucleotide synthase-1/dehydrocholesterol reductase-7, vitamin D receptor, group-specific component, CYP2R1) and disease severity. †Joint senior authors. Methods: In 103 paediatric patients with NAFLD, serum 25-hydroxyvitamin D Address for correspondence: (25OHD) levels and genotypes were determined contemporaneously to liver biopsy Dr. J Bernadette Moore, University of and examined in relation to NAFLD activity score and fibrosis stage. Leeds, School of Food Science and Nutrition, West Yorkshire, Leeds Results: Only 19.2% of children had adequate vitamin D status; most had mean fi < À1 fi LS2 9JT, UK.
    [Show full text]
  • Cell Culture-Based Profiling Across Mammals Reveals DNA Repair And
    1 Cell culture-based profiling across mammals reveals 2 DNA repair and metabolism as determinants of 3 species longevity 4 5 Siming Ma1, Akhil Upneja1, Andrzej Galecki2,3, Yi-Miau Tsai2, Charles F. Burant4, Sasha 6 Raskind4, Quanwei Zhang5, Zhengdong D. Zhang5, Andrei Seluanov6, Vera Gorbunova6, 7 Clary B. Clish7, Richard A. Miller2, Vadim N. Gladyshev1* 8 9 1 Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard 10 Medical School, Boston, MA, 02115, USA 11 2 Department of Pathology and Geriatrics Center, University of Michigan Medical School, 12 Ann Arbor, MI 48109, USA 13 3 Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, 14 MI 48109, USA 15 4 Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 16 48109, USA 17 5 Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10128, USA 18 6 Department of Biology, University of Rochester, Rochester, NY 14627, USA 19 7 Broad Institute, Cambridge, MA 02142, US 20 21 * corresponding author: Vadim N. Gladyshev ([email protected]) 22 ABSTRACT 23 Mammalian lifespan differs by >100-fold, but the mechanisms associated with such 24 longevity differences are not understood. Here, we conducted a study on primary skin 25 fibroblasts isolated from 16 species of mammals and maintained under identical cell culture 26 conditions. We developed a pipeline for obtaining species-specific ortholog sequences, 27 profiled gene expression by RNA-seq and small molecules by metabolite profiling, and 28 identified genes and metabolites correlating with species longevity. Cells from longer-lived 29 species up-regulated genes involved in DNA repair and glucose metabolism, down-regulated 30 proteolysis and protein transport, and showed high levels of amino acids but low levels of 31 lysophosphatidylcholine and lysophosphatidylethanolamine.
    [Show full text]
  • Genome-Wide Association Study of Vitamin D Levels in Children: Replication in the Western Australian Pregnancy Cohort (Raine) Study
    Genes and Immunity (2014) 15, 578–583 © 2014 Macmillan Publishers Limited All rights reserved 1466-4879/14 www.nature.com/gene SHORT COMMUNICATION Genome-wide association study of vitamin D levels in children: replication in the Western Australian Pregnancy Cohort (Raine) study D Anderson1, BJ Holt1, CE Pennell2, PG Holt1, PH Hart1 and JM Blackwell1 This genome-wide association study (GWAS) utilises data from the Western Australian Pregnancy Cohort (Raine) Study for 25- hydroxyvitamin D (25(OH)D) levels measured in blood collected at age 6 years (n = 673) and at age 14 years (n = 1140). Replication of significantly associated genes from previous GWASs was found for both ages. Genome-wide significant associations were found both at age 6 and 14 with single nucleotide polymorphisms (SNPs) on chromosome 11p15 in PDE3B/CYP2R1 (age 6: rs1007392, P = 3.9 × 10 − 8; age14: rs11023332, P = 2.2 × 10 − 10) and on chromosome 4q13 in GC (age 6: rs17467825, P = 4.2 × 10 − 9; age14: rs1155563; P = 3.9 × 10 − 9). In addition, a novel association was observed at age 6 with SNPs on chromosome 7p15 near NPY (age 6: rs156299, P = 1.3 × 10 − 6) that could be of functional interest in highlighting alternative pathways for vitamin D metabolism in this age group and merits further analysis in other cohort studies. Genes and Immunity (2014) 15, 578–583; doi:10.1038/gene.2014.52; published online 11 September 2014 INTRODUCTION RESULTS AND DISCUSSION In humans, vitamin D is obtained primarily through exposure to Descriptive statistics of the study participants are shown in ultraviolet B radiation from sunlight and secondarily through a Table 1.
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]